People mainly take Bacopa 24% for memory, anxiety, mood. Based on 3 first-hand reports and 2 meta-analyses & systematic reviews in the medical literature. Ranked #2775 of 3,539 overall.
Of reports that state an outcome, 0% are positive.
Of the people who reported each effect, the share who said it got better.
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found.
Conclusion: This meta-analysis suggests that Bacopa monnieri has the potential to improve cognition, particularly speed of attention but only a large well designed 'head-to-head' trial against an existing medication will provide definitive data on its efficacy on healthy or dementia patients using a standardized preparation.
PubMed 24252493 ↗Conclusion: Brahmi, particularly in high-dose formulations, shows promise as a cognitive enhancer compared to Ginkgo in healthy adults. However, the lack of direct comparisons may limit the strength of this evidence.
PubMed 41678913 ↗As stated by users — not a recommendation. Follow the label or your doctor.
How often each side effect came up across all reports.
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“after using regular Bacopa for a few days I always start to feel excessively lethargic and and sort of emotionally dead”
“After that I've tried both synapsa and the 24% extract from ND(still take the 24% sometimes) but I have never been able to replicate the same effects.”
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate